01 October 2003
Delirium due to Buprenorphine therapy
Alexander Kaptsan, Darwin TeliasCase Rep Clin Pract Rev 2003; 4(3):182-185 :: ID: 450617
Abstract
Background: Buprenorphine, a mixed agonist-antagonist opioid, is a potent analgesic that appears to be effective for the maintenance treatment of opiate abuse. We did not find published reports of buprenorphine-induced delirium in opioid users and now describe a patient who developed delirium probably due to buprenorphine treatment.
Case report: The following report describes a case in which a physically healthy patient suffering from opioid abuse developed delirium under buprenorphine therapy. The patient was confused, had visual and verbal hallucinations, delusions of reference, influence and persecution, which were successfully treated by termination of buprenorphine and treatment with haloperidol.
Conclusions: The intention of this report is to draw new attention to the adverse event, which may represent a dangerous side effect of treatment with a relatively novel medication. Some speculations about possible mechanisms and clinical implication are discussed. Further systematic study would be required, if a significant number of cases.
Keywords: Buprenorphine, side effect, Delirium
562
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945294
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945747
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945539
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.945795
Most Viewed Current Articles
21 Jun 2024 : Case report
88,402
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
49,961
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report
25,080
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
22,629
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030